Aspen Aerogels, Inc. ASPN · NYSE
$5.34 +0.38% (+$0.02)
Summary
57 / 100 · Bulios Score
What speaks for it
- It earns 61 USD a year on every 100 USD of invested capital.
- Revenue grew by 15% a year over the last 3 years.
- It holds more cash than debt: $151.7M against $125.1M.
- The share price is below the Bulios Fair Price.
What to watch
- The company made a loss over the last 12 months.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 22% a year over 5 years. Over the last 3 years it grew by 15% a year.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $126.2M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 3.3 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 19
- Hold 3
- Sell 1
Today's price within the analysts' price targets
The average target of $6.38 is 20% above today's price. 83% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Thermal Barrier 62%
- Energy Industrial 38%
By region
- UNITED STATES 46%
- International 27%
- Latin America 13%
- Asia 8.4%
- Europe 4.8%
- Other 0.7%
Thermal Barrier brings in 62% of revenue.
Segments in detail